Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,740,558
-$46,966,908 QoQ
Shares Held
40,563
-96.6% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 217 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Derivatives in VERA
reported options exposure · as of Mar 31, 2026CallValue
$358,047
CallShares
8,900
PutValue
$358,047
PutShares
8,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. VERA ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in VERA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,740,558 | 40,563 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $358,047 | 8,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $358,047 | 8,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $48,707,466 | 1,210,725 | Shares | Defined | 2026-05-15 | |
| 2026-03-25 | $49,377,724 | 1,229,525 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $88,031,816 | 1,738,385 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $36,965,104 | 1,272,027 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $8,205,401 | 194,027 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,583,526 | 171,573 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,305,420 | 119,000 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $50,672,381 | 1,175,148 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,138,903 | 984,324 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $8,048,113 | 1,037,128 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $2,578,510 | 121,000 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||